Article
A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention.
BMC cancer - 5 Mar 2018
Hanley Gillian E, McAlpine Jessica N, Miller Dianne, Huntsman David, Schrader Kasmintan A, Blake Gilks C, Mitchell Gillian
Abstract excerpt
BACKGROUND: Identifying female carriers of BRCA1 and BRCA2 mutations is imperative for prevention of ovarian cancer and breast cancer. There are five major histologic subtypes of ovarian cancer and high grade serous cancer (the most common) is reported in 75-100% of BRCA1 and BRCA2 mutation carriers. We examined histology-based referral to the Hereditary Cancer Program following an educational prevention campaign...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
